home / United States / Gyre Therapeutics

Gyre Therapeutics Market Cap

$0.92 B

-0.02 B

NASDAQ:GYRE · January 22, 2025

Share price

$10.70

Enterprise Value

$1.25 B

Change (1-Year)

-32.2%

Global Rank

#5329

Country Rank

#2013

Regions

USA

Market cap

As of January 22, 2025, Gyre Therapeutics (GYRE) has a market cap of $0.92 billion USD. According to our data, Gyre Therapeutics is ranked No.5329 in global market value.

Sector Rank:

Biotech #293 Pharmaceuticals #266

GYRE Market Capitalization Growth

30D Growth:

-8.0%

1 Years Growth:

-32.2%

3 Years Growth:

612.0%

5 Years Growth:

-34.5%

10 Years Growth:

-97.7%

15 Years Growth:

-99.7%

20 Years Growth:

-99.3%

Total Growth:

-99%

Gyre Therapeutics Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Gyre Therapeutics Market Cap CAGR Chart

Gyre Therapeutics Market Cap History 2006 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$0.92 B	-11.57%
Dec 31, 2024	$1.04 B	-52.90%
Dec 29, 2023	$2.20 B	422.00%
Dec 30, 2022	$0.42 B	121.55%
Dec 31, 2021	$0.19 B	-85.58%
Dec 31, 2020	$1.32 B	-7.34%
Dec 31, 2019	$1.43 B	-13.69%
Dec 31, 2018	$1.65 B	-42.16%
Dec 29, 2017	$2.86 B	39.90%
Dec 30, 2016	$2.04 B	-79.23%
Dec 31, 2015	$9.84 B	-77.10%
Dec 31, 2014	$42.96 B	-36.63%
Dec 31, 2013	$67.79 B	-5.25%
Dec 31, 2012	$71.54 B	-21.36%
Dec 30, 2011	$90.98 B	-78.98%
Dec 31, 2010	$432.85 B	26.79%
Dec 31, 2009	$341.38 B	487.08%
Dec 31, 2008	$58.15 B	-56.90%
Dec 31, 2007	$134.92 B	-8.73%
Dec 29, 2006	$147.82 B	100%

Similar Companies to Gyre Therapeutics

Name	Market Cap	Market cap difference	Regions
Amgen AMGN	$146.98 B	0.004 M	USA
Gilead Sciences GILD	$115.95 B	0.002 M	USA
Biogen BIIB	$20.80 B	0.000 M	USA
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Vertex Pharmaceuticals VRTX	$110.22 B	0.001 M	USA
Moderna MRNA	$14.82 B	-0.000 M	USA
BioMarin Pharmaceutical BMRN	$11.82 B	0.000 M	USA
Alnylam Pharmaceuticals ALNY	$34.38 B	-0.000 M	USA
Incyte INCY	$13.95 B	-0.000 M	USA
Illumina ILMN	$22.26 B	0.000 M	USA
Sarepta Therapeutics SRPT	$11.09 B	0.000 M	USA
Ionis Pharmaceuticals IONS	$5.13 B	-0.000 M	USA
bluebird bio BLUE	$76.22 M	0.000 M	USA
CRISPR Therapeutics CRSP	$3.77 B	-0.000 M	Switzerland

About Gyre Therapeutics Inc.

Name

Gyre Therapeutics, Inc.

Website

https://www.gyretx.com

Headquarters

San Diego,CA

symbol

GYRE

CURRENCY

USD

country

United States

fullTimeEmployees

593

exchange

NCM

firstTradeDateEpochUtc

2006/04/12

GYRE Market Cap Formula

Market Cap	=	GYRE Stock Price	*	GYRE Shares Outstanding
	=	$10.70	*	85.82 M
	=	$0.92 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe